Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study)

2004 BMJ (Clinical Research Edition)  
doi:10.1136/bmj.328.7441.686-b fatcat:nsen4cdhdbexdla53fh6v74apm